当前位置：
主页产品
详情

4-tert-Butylphenyl glycidyl ether | CAS:3101-60-8

4-tert-Butylphenyl glycidyl ether

名称：4-叔丁基苯基缩水甘油醚 | 4-tert-Butylphenyl glycidyl ether
CAS号：3101-60-8
别名：p-tert-Butylphenyl 1-(2,3-epoxy)propyl ether
分子式：C₁₃H₁₈O₂
分子量：206.28
EINESC号：221-453-2

产品描述

物理化学性质

沸点	165-170 ºC
闪点	102 ºC
密度	1.038
折射率	1.515

安全数据

没有数据	没有数据

SDS

来源	SDS样本
Alfa-Aesar	浏览或下载
Sigma-Aldrich	浏览或下载

产品合成路线

名称	CAS号

文章

同行评议文献

Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases.Tudor I Oprea et al.PloS one, 10(11), e0142182-e0142182 (2015-11-13) Enantiomer?selective pharmacokinetics and metabolism of ketorolac in children.Kauffman RE, et al. Clinical Pharmacology and Therapeutics, 65(4), 382-388 (1999) Drug Repurposing from an Academic Perspective.Tudor I Oprea et al.Drug discovery today. Therapeutic strategies, 8(3-4), 61-69 (2012-03-01) The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.Hayball PJ, et al. British Journal of Clinical Pharmacology, 37(1), 75-78 (1994) R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.Yuna Guo et al.Molecular cancer therapeutics, 14(10), 2215-2227 (2015-07-25) A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.Yuna Guo et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 21(22), 5064-5072 (2015-06-14)

备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称	CAS号

产品描述

物理化学性质

安全数据

SDS

相关产品

相关资讯